Resources

2 Resources for

roche holding ag

Subscribe to this listing via:
RSS
Email

BNET Resources

NICE Rejects Cancer Drug in Clash With Roche: LONDON/ZURICH (Reuters UK) - Roche's ROG cancer drug Avastin will not be made available for use on Britain's state health service because the Swiss drugmaker has refused to provide enough information to assess its cost-effectiveness. The National Institute for Clinical Health and Excellence NICE said...; Tags: Roche Holding AG, Health Service, Breast Cancer, Lung, Health Care, Avastin, NICE, Genentech Inc., Rogers Corp.; News items 2008-06-26
Roche Diagnostics - Anatomy Of A Serious Data Breach: This paper explores how breaches of security can ruin even the most innocent of newsletters and tells you how you can avoid making the same mistakes. The paper explains simple checklist of things to do in order to be both lawful and ethical: make the email address at least of...; Tags: e-mail address, e-mail, newsletter, marketing, security; White papers 2007-08-21

Additional Resources

Drug war: DRUG WAR: Roche Holding AG agreed to pay Amgen Inc. a higher royalty fee than it proposed earlier, with the goal of getting its anemia drug Mircera onto the U.S. market despite a legal challenge from Amgen. Thousand Oaks-based Amgen asked a U.S. Court to grant a permanent injunction barring...; Articles 2008-03-24
CHYFF, CGEMY, DNSKY, RHHBY, TLEI Have Also Been Removed From Naked Short List Today.: M2 PRESSWIRE-25 February 2008-BUYINS.NET: CHYFF, CGEMY, DNSKY, RHHBY, TLEI Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:25022008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE...; Articles 2008-02-25
Aruba shares take tumble: Shares of networking equipment maker Aruba Networks Inc. of Sunnyvale fell $2.84, or 36.6 percent, to $4.92 Friday, which is the biggest drop since its March initial public offering. The maker of wireless networking equipment said in a statement of preliminary results that second-quarter revenue was as much as $41...; Articles 2008-02-09

AHMIQ, RHHBY Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days.: M2 PRESSWIRE-23 January 2008-BUYINS.NET: AHMIQ, RHHBY Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading DaysC1994-2008 M2 COMMUNICATIONS LTD RDATE:23012008 BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE...; Articles 2008-01-23
Drug war: Swiss biotech company Roche Holding AG has received approval from U.S. regulators for its anemia drug Mircera even though the drug that has been found to violate patents held by competing biotech firm Amgen Inc. Mircera was approved by the U.S. Food and Drug Administration for patients with anemia caused...; Articles 2007-11-26
2 common flu drugs should carry warnings, feds say: Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, the two most common drugs used to treat and prevent flu, should carry warnings that they may cause psychiatric side effects, U.S. regulators recommended. The report by staff members of the U.S. Food and Drug Administration was posted Friday,...; Articles 2007-11-24
Fish oil, caffeine may thwart Alzheimer's: Blood pressure drugs made by GlaxoSmithKline Plc and Roche Holding AG, caffeine and fish oil all may help treat, prevent or delay Alzheimer's disease, researchers found in separate studies. The drugs, all available in generic form, appear to block formation of sticky wads of protein called amyloid...; Articles 2007-11-08
Amgen affairs: Amgen Affairs: Amgen Inc. won a jury verdict that should prevent Roche Holdings AG from selling its version of a competing anemia medicine in the U.S. A federal jury in Boston ruled that Roche's drug, Mircera, which is still in development, would infringe on three existing Amgen patents related to...; Articles 2007-10-29
Acrongenomics Inc.: Appointment of CEO.: VANCOUVER, BRITISH COLUMBIA, Aug 6, 2007 CCNMatthews via COMTEX -- Acrongenomics Inc., (OTCBB:AGNM) has appointed Dr. Dimitri Goundis as its Chief Executive Officer CEO effective as of September 3, 2007, bringing his important international experience in science, business and management to the company. ...; Articles 2007-08-06
Acrongenomics Inc.: Appointment of CEO: Acrongenomics Inc., (OTCBB: AGNM) has appointed Dr. Dimitri Goundis as its Chief Executive Officer CEO effective as of September 3, 2007, bringing his important international experience in science, business and management to the company. Dr. Goundis holds a Ph.D. in Biochemistry from the University of Oxford, a B.Sc. in Chemistry/Biochemistry...; Articles 2007-08-06
Top 50 packagers: pharmaceutical: TOP 50PACKAGERS: PHARMACEUTICAL2007 2006 Company Total RevenuesRank Rank Headquarters ...; Articles 2007-07-01
Shareholders of Gaithersburg-based BioVeris Corp. approves: BioVeris Corp.'s shareholders voted Monday to approve the company's $600 million acquisition by Basel, Switzerland-based Roche Holding AG. Roche, the world's biggest maker of diagnostic tests, agreed to pay $21.50 a share in cash -- a total of $600 million -- to acquire Gaithersburg-based BioVeris, a manufacturer of diagnostic equipment....; Articles 2007-06-27
Ventana Medical Systems Inc Sees Hostile Bid.: M2 PRESSWIRE-27 June 2007-investorIM: Ventana Medical Systems Inc Sees Hostile BidC1994-2007 M2 COMMUNICATIONS LTD RDATE:27062007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a ...; Articles 2007-06-27
Stock Watch Update.: M2 PRESSWIRE-21 June 2007-Financialbusinessnews.us: Stock Watch UpdateC1994-2007 M2 COMMUNICATIONS LTD RDATE:21062007 Boston, MA - FinancialBusinessNews' Afternoon "Stocks To Watch": ROCHE HOLDING LTD. (PINKSHEETS: RHHBY); SUN SPORTS & ENTERTAINMENT INC. (PINKSHEETS: SSPE); SILVERADO GOLD MINES LTD (OTCBB: SLGLF)...; Articles 2007-06-21
Rockville-based Institutional Shareholder Service supports BioVeris: BioVeris Corp.'s shareholders should vote in favor of the company's pending merger with a subsidiary of Roche Holding AG, a second proxy advisory firm said. The recommendation from Rockville- based Institutional Shareholder Services, a provider of proxy voting and corporate governance data services, follows the same advice from Glass Lewis...; Articles 2007-06-15
Roche research.(Branded Drugs)(Roche Holding Ltd.)(Brief article): Roche Holding AG says it will boost spending on R&D. Studies on cancer drugs will be conducted out of the company's U.S. subsidiary in New Jersey. Research on virology and inflammation will be carried out in California...; Articles 2007-02-19
GSK gets O.K to sell weight loss drug as O-T-C.(News)(GlaxoSmithKline PLC)(Brief article): WASHINGTON -- Glaxo-SmithKline PLC's (GSK's) consumer health care division has won Food and Drug Administration approval to sell orlistat, a weight loss drug, over the counter. The product will be marketed under the alli brand name. Although a significant number of herbal supplements...; Articles 2007-02-19
Diet pill over counter for first time: WASHINGTON -- Dieters got a new tool Wednesday to help them take off the extra pounds -- the first government-approved nonprescription diet pill. The Food and Drug Administration said the fat-blocking weight- loss pill orlistat, which has been available by prescription, can be sold in a reduced-strength...; Articles 2007-02-08

<< Previous
page 1 of 1
Next >>

Content Types

News items (1 results)

White papers (1 results)

Resources

roche holding ag

BNET Resources

Additional Resources

Content Types

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors